How Does Cost-Sharing Impact Spending Growth and Cost-Effective Treatments?
The growth of health care spending has been a longstanding policy concern. Over the years, several innovations have been proposed [...]
ICER Embarks on Annual Assessment of Insurance Coverage
The Institute for Clinical and Economic Review (ICER) is holding a review of current coverage policies of US insurers and [...]
ICER Publishes White Paper on Fair Patient Access to Prescription Drugs
The Institute for Clinical and Economic Review (ICER) published a new white paper entitled: "Cornerstones of 'Fair' Drug Coverage: Appropriate [...]
How COVID-19 Provides Opportunities to Implement Value-Based Care Practices
COVID-19 has drastically changed the healthcare landscape for payers and providers as telehealth services are increasingly utilized. Experts discussed how [...]
New Data Released: Higher cost-sharing for brand medicines experienced by commercially insured patients
Health plans are increasingly using deductibles and coinsurance to shift more of the cost of care to chronically ill patients [...]